Belite Bio completes FDA drug application for rare eye disease treatment
Go back to Belite Bio completes FDA drug application for rare eye disease treatment| (NASDAQ: BLTE) | Delayed: 144.64 -2.43 (1.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $147.07 | 52 Week High | $ | |||
| Open | $145.94 | 52 Week Low | $ | |||
| Day High | $148.65 | P/E | N/A | |||
| Day Low | $144.64 | EPS | $ | |||
| Volume | 50,686 | |||||
